Maryam Daneshpazhooh

InstitutionTehran University of Medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 12 Covid-19 publications, with a maximum of 2 publications in Spetember 2020 and December 2020
    All Publications
    Bar chart showing 96 publications over 18 distinct years, with a maximum of 14 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tavakolpour S, Aryanian Z, Seirafianpour F, Dodangeh M, Etesami I, Daneshpazhooh M, Balighi K, Mahmoudi H, Goodarzi A. A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns. Immunopharmacol Immunotoxicol. 2021 Oct; 43(5):507-518. PMID: 34287098.
      Citations: 2     Fields:    Translation:Humans
    2. Mahmoudi H, Farid AS, Nili A, Dayani D, Tavakolpour S, Soori T, Teimourpour A, Isazade A, Abedini R, Balighi K, Daneshpazhooh M. Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study. J Am Acad Dermatol. 2021 04; 84(4):1098-1100. PMID: 33359593.
      Citations: 6     Fields:    Translation:Humans
    3. Daneshpazhooh M, Mahmoudi H. COVID-19: The experience from Iran. Clin Dermatol. 2021 Jan-Feb; 39(1):23-32. PMID: 33972048.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Sadeghinia A, Daneshpazhooh M. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review. Dermatol Ther. 2021 Jan; 34(1):e14498. PMID: 33141519.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    5. Nili A, Zarei E, Ghamari A, Farid AS, Tavakolpour S, Daneshpazhooh M, Mahmoudi H. Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital. Int Immunopharmacol. 2020 Dec; 89(Pt B):107093. PMID: 33091817.
      Citations:    Fields:    Translation:Humans
    6. Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic". J Am Acad Dermatol. 2021 01; 84(1):e61-e62. PMID: 32896598.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Mahmoudi H, Tavakolpour S, Nili A, Salehi Farid A, Daneshpazhooh M, Rashidian M. Treatment of pemphigus patients in the COVID-19 era: A specific focus on rituximab. Dermatol Ther. 2020 11; 33(6):e14188. PMID: 32794333.
      Citations: 1     Fields:    Translation:HumansCells
    8. Amir Dastmalchi D, Moslemkhani S, Bayat M, Balighi K, Abedini R, Mahmoudi H, Daneshpazhooh M. The efficacy of rituximab in patients with mucous membrane pemphigoid. J Dermatolog Treat. 2020 Aug 11; 1-7. PMID: 32723108.
      Citations: 2     Fields:    
    9. Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M. Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era. Dermatol Ther. 2020 Nov; 33(6):e13956. PMID: 32621628.
      Citations: 4     Fields:    Translation:Humans
    10. Daneshpazhooh M, Soori T, Isazade A, Noormohammadpour P. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. J Dermatolog Treat. 2020 Aug; 31(5):446-447. PMID: 32363963.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    11. Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. Treatment considerations for patients with pemphigus during the COVID-19 pandemic. J Am Acad Dermatol. 2020 06; 82(6):e235-e236. PMID: 32283243.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    Daneshpazhooh's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (225)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _